Oral contraceptive use, thrombophilia and their interaction in young women with ischemic stroke.
 |
Related Articles |
Oral contraceptive use, thrombophilia and their interaction in young women with ischemic stroke.
Haematologica. 2006 Jun;91(6):844-7
Authors: Martinelli I, Battaglioli T, Burgo I, Di Domenico S, Mannucci PM
To investigate the role of oral contraceptives and their interaction with thrombophilia in ischemic stroke, a case-control study on women with a first ischemic stroke when younger than 45 years was carried out. Oral contraceptives doubled the risk of ischemic stroke in the first 6-18 months of use and hyperhomocysteinemia increased the risk by 3.5-fold. Carriers of factor V Leiden or prothrombin G20210A were not found to have a statistically significant increased risk. The risk of ischemic stroke in oral contraceptive users was 13 times higher in women who were also carriers of factor V Leiden and 9 times higher in those who also had hyperhomocysteinemia.
PMID: 16769590 [PubMed - in process]
Related posts:
- Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials.
- Influence of gender on outcomes after intra-arterial thrombolysis for acute ischemic stroke.
- Toward a Further Elucidation: Role of Vertebral Artery Hypoplasia in Acute Ischemic Stroke.
- Genetic Variants of Arachidonate 5-Lipoxygenase-Activating Protein, and Risk of Incident Myocardial Infarction and Ischemic Stroke. A Nested Case-Control Approach.
- Prothrombotic risk factors in ischemic stroke and migraine in children.